MicroRNA-25 aggravates Aβ1-42-induced hippocampal neuron injury in Alzheimer's disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model

J Cell Biochem. 2019 Sep;120(9):15891-15905. doi: 10.1002/jcb.28861. Epub 2019 May 29.

Abstract

Recently, numerous microRNAs (miRNAs) have been considered as key players in the regulation of neuronal processes. The purpose of the present study is to explore the effect of miR-25 on hippocampal neuron injury in Alzheimer's disease (AD) induced by amyloid β (Aβ) peptide fragment 1 to 42 (Aβ1-42) via Kruppel-like factor 2 (KLF2) through the nuclear factor-E2-related factor 2 (Nrf2) signaling pathway. A mouse model of AD was established through Aβ1-42 induction. The underlying regulatory mechanisms of miR-25 were analyzed through treatment of miR-25 mimics, miR-25 inhibitors, or small interfering RNA (siRNA) against KLF2 in hippocampal tissues and cells isolated from AD mice. The targeting relationship between miR-25 and KLF2 was predicted using a target prediction program and verified by luciferase activity determination. MTT assay was used to evaluate the proliferative ability and flow cytometry to detect cell cycle distribution and apoptosis. KLF2 was confirmed as a target gene of miR-25. When the mice were induced by Aβ1-42, proliferation was suppressed while apoptosis was promoted in hippocampal neurons as evidenced by lower levels of KLF2, Nrf2, haem oxygenase, glutathione S transferase α1, glutathione, thioredoxin, and B-cell lymphoma-2 along with higher bax level. However, such alternations could be reversed by treatment of miR-25 inhibitors. These findings indicate that miR-25 may inhibit hippocampal neuron proliferation while promoting apoptosis, thereby aggravating hippocampal neuron injury through downregulation of KLF2 via the Nrf2 signaling pathway.

Keywords: Alzheimer's disease; Kruppel-like factor 2; amyloid β peptide fragment 1 to 42; hippocampal neuron injury; microRNA-25; nuclear factor-E2-related factor 2 signaling pathway.

MeSH terms

  • Alzheimer Disease / genetics*
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Peptides / toxicity
  • Animals
  • Apoptosis
  • Cell Proliferation
  • Cells, Cultured
  • Disease Models, Animal
  • Down-Regulation
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Kruppel-Like Transcription Factors / genetics*
  • Kruppel-Like Transcription Factors / metabolism
  • Male
  • Mice
  • MicroRNAs / genetics*
  • NF-E2-Related Factor 2 / genetics*
  • NF-E2-Related Factor 2 / metabolism
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Peptide Fragments / metabolism*
  • Peptide Fragments / toxicity
  • Signal Transduction

Substances

  • Amyloid beta-Peptides
  • Klf2 protein, mouse
  • Kruppel-Like Transcription Factors
  • MIRN25 microRNA, mouse
  • MicroRNAs
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Peptide Fragments
  • amyloid beta-protein (1-42)